Nisa Investment Advisors’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
RI
PCM
VCM
SPPAM
VPM
Nisa Investment Advisors's CSTL Position: Q1 2026 in Review
Nisa Investment Advisors reduced its Castle Biosciences (CSTL) stake by 8.9% in Q1 2026, selling an estimated $819 and leaving 256 shares worth $6.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2399.
Nisa Investment Advisors first reported a position in CSTL in Q4 2020 and has held it in 22 quarters since. The position peaked at $27K in Q4 2020. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.
- Nisa Investment Advisors held 256 shares of Castle Biosciences worth $6.29K as of Q1 2026.
- Nisa Investment Advisors sold 25 Castle Biosciences shares in Q1 2026, an estimated $819.
- Castle Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2399 holding.
- Nisa Investment Advisors first reported a position in Castle Biosciences in Q4 2020 and has held it in 22 quarters since.
- Nisa Investment Advisors's Castle Biosciences position peaked at $27K in Q4 2020.
- 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.